DCM
KMTS

Driehaus Capital Management’s Kestra Medical Technologies KMTS Stock Holding History

Driehaus Capital Management’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.91M Sell
447,315
-15,746
-3% -$371K 0.07% 274
2025
Q4 		$12.3M Buy
+463,061
New +$11.9M 0.08% 266

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AP
Andera Partners Paris $177M AUM
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Driehaus Capital Management's KMTS Position: Q1 2026 in Review

Driehaus Capital Management reduced its Kestra Medical Technologies (KMTS) stake by 3.4% in Q1 2026, selling an estimated $371K and leaving 447,315 shares worth $8.91M. The position accounts for 0.07% of the portfolio, ranked #274.

Driehaus Capital Management first reported a position in KMTS in Q4 2025 and has held it in 2 quarters since. The position peaked at $12.3M in Q4 2025. 103 funds tracked by Wall St. Rank hold KMTS as of Q1 2026.

  • Driehaus Capital Management held 447,315 shares of Kestra Medical Technologies worth $8.91M as of Q1 2026.
  • Driehaus Capital Management sold 15,746 Kestra Medical Technologies shares in Q1 2026, an estimated $371K.
  • Kestra Medical Technologies made up 0.07% of Driehaus Capital Management's portfolio in Q1 2026, its #274 holding.
  • Driehaus Capital Management first reported a position in Kestra Medical Technologies in Q4 2025 and has held it in 2 quarters since.
  • Driehaus Capital Management's Kestra Medical Technologies position peaked at $12.3M in Q4 2025.
  • 103 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q1 2026.

Based on Driehaus Capital Management's 13F filing for Q1 2026, filed 15 May 2026.